Characteristics of Patients Locoregionally Treated with 90Y-DOTATOC
| Patient no. | Age (y) | Sex | Previous treatment | Injected activity 90Y (GBq) | SRC τ (h) | Blood τ (h) | Urine cumulative activity (%) | Urine τ (h) |
|---|---|---|---|---|---|---|---|---|
| 1 | 51 | M | RT, CH | 0.9 | 68.6 | ne | 27.2 | 0.67 |
| 2 | 51 | M | RT, CH | 1.1 | 73.2 | 0.31 | 23.1 | 0.73 |
| 3 | 51 | M | RT, CH | 0.9 | 59.5 | ne | 41.6 | 1.01 |
| 4 | 62 | M | RT, CH | 1.0 | 52.5 | 0.79 | 47.9 | 1.13 |
| 5 | 42 | F | RT, CH | 0.9 | 58.8 | 0.49 | 41.3 | 0.88 |
| 6 | 41 | M | CH | 0.6 | 49.8 | 0.51 | 35.8 | 1.03 |
| 7 | 68 | M | CH | 0.7 | 47.7 | 0.80 | 53.7 | 1.3 |
| 8 | 53 | F | RT, CH | 0.4 | 70.9 | 0.38 | 25.6 | 0.74 |
| 9 | 32 | F | CH | 0.5 | 68.7 | 0.25 | 28.8 | 0.68 |
| 10 | 63 | F | CH | 0.7 | 56.7 | 0.47 | 47.2 | 1.29 |
| 11 | 45 | M | RT, CH | 0.7 | 59.6 | 0.52 | 40.1 | 1.14 |
| 12 | 73 | F | RT, CH | 0.7 | 61.5 | 0.59 | 37.4 | 1.05 |
ne = not evaluated.